Orally taken traditional Chinese medicine composition for treating rigidity rachitis

Abstract

The invention discloses an oral administration pharmaceutical composition for treating rigid rachitis, which is prepared from processed radix aconiti kusnezoffii 10g, processed radix aconiti 10g, tetrandra root 5g, Clematis chinensis 10g, astragalus root 8g, spatholobus stem 5g, licorice root 2g, Loranthus mulberry mistletoe 8g, pyrola 12g, pubescent angelica root 10g, futokadsura stem 6g, homalomena rhizome 8g, Loranthus mulberry mistletoe 6g, tiger bone 7g and Achyranthes bidentatae 5g. The medicament should be decocted in water for the oral dose.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for oral administration for treating ankylosing spondylitis, which belongs to the field of traditional Chinese medicines. Background technique [0002] Ankylosing spondylitis belongs to the category of rheumatic diseases and is one of the seronegative spondyloarthropathies. Ankylosing spondylitis refers to a chronic disease whose cause is not yet clear, with the spine as the main lesion. The lesion mainly involves the sacroiliac joints, causing spinal ankylosing and fibrosis, resulting in bending and limited walking activities. Degree of eye, lung, muscle, bone lesions, as well as autoimmune disorders, so it is also an autoimmune disease. The manifestations of the disease are various, and it is easy to be misdiagnosed. If the treatment is delayed or improperly treated, it can cause permanent disability. Therefore, once you have the above symptoms, you must go to a regular hospital in...

AI Technical Summary

Problems solved by technology

[0003] At present, there are many drugs and methods for the treatment of rheumatoid and ankylosing spondylitis at home and abroad, traditional Chinese and Western medicine, all of which use immune preparations, non-steroidal drugs and some traditional Chinese medicines to anti-inflammatory, analgesic, relieve stiffness symptoms, and delay the development of the disease, but they cannot prevent the disease from developing. Destruction of the synovium and periosteum and bone mass in the disease

There is nothing to do about the bone lesions that have already occurred, and although hormone drugs can relieve the pain symptoms of patients, they will aggravate the damage to the bone and eventually cause necrosis of the femoral head, thus making the condition even worse